Cell Proliferation
DiviTum® TKa Test
DiviTum® TKa is a new blood test that has been uniquely designed for monitoring disease progression by measuring cell proliferation from solid tumors.
Events
See our investor events
Stream our recent live events with the latest information communicated to the market. Have a look at video interviews with Anders Rylander, CEO, and Warren Cresswell, President Americas, as well as other company presentations.
Who We Help
What oncologists say
These results should serve as the basis for future clinical studies to distinguish patients with estrogen receptor-positive metastatic breast cancer who might be best treated with endocrine therapy alone.
University of Michigan Rogel Cancer Center
Do you want to be a part of our journey?
>4,500
Numbers of patients in studies
28
Publications
22
Pharma Projects